ArticleScientific reports2025
Multimodal surface-based transformer model for early diagnosis of Alzheimer's disease.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A survey of deep learning techniques in detecting neurological disorders using MRI.Biomedical engineering online · 2026Pooled it
- Hippocampal surface analysis using discrete Ricci flow and Riemannian metrics for the diagnosis of Alzheimer's disease.Research square · 2026Article
- Intra-scale interaction and cross-scale fusion network for detecting the progression of neurodegeneration in Alzheimer's disease.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Current deep learning methods for diagnosing Alzheimer's disease (AD) typically rely on analyzing all or parts of high-resolution 3D volumetric features, which demand expensive computational resources and powerful GPUs, particularly when using multimodal data. In contrast, lightweight cortical surface representations offer a more efficient approach for quantifying AD-related changes across different cortical regions, such as alterations in cortical structures, impaired glucose metabolism, and the deposition of pathological biomarkers like amyloid-β and tau. Despite these advantages, few studies have focused on diagnosing AD using multimodal surface-based data. This study pioneers a novel method that leverages multimodal, lightweight cortical surface features extracted from MRI and PET scans, providing an alternative to computationally intensive 3D volumetric features. Our model employs a middle-fusion approach with a cross-attention mechanism to efficiently integrate features from different modalities. Experimental evaluations on the ADNI series dataset, using T1-weighted MRI and [Formula: see text]Fluorodeoxyglucose PET, demonstrate that the proposed model outperforms volume-based methods in both early AD diagnosis accuracy and computational efficiency. The effectiveness of our model is further validated with the combination of T1-weighted MRI, Aβ PET, and Tau PET scans, yielding favorable results. Our findings highlight the potential of surface-based transformer models as a superior alternative to conventional volume-based approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.